An interventional study of Levels of Diagnostic and Therapeutic Intervention tool by Fontecha and col. and Usual clinical practice in Acute Disease, sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. Withdrawn at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by Consorci Sanitari de l'Alt Penedès i Garraf · Not applicable, Interventional, and Supportive care
Feasibility issues (organizational changes required to perform the trial are not feasible)
The objective of this clinical trial is to investigate the impact of implementing a tool for adjusting the level of diagnostic and therapeutic intensity in the clinical practice of physicians attending hospitalized patients.
The goal of this clinical trial is to investigate the impact of a tool for adjusting diagnostic and therapeutic intensity in hospitalized patients. The main question it aims to answer is: Is there a difference in patient mortality when using the aforementioned tool? The participating physicians will be grouped into 4 groups (5 physicians each). Each group will progressively (every 3 months) incorporate the use of the aforementioned tool into their usual clinical practice.
57 studies on the registry are indexed under Acute Disease; 12 are open to participants now.
Browse Acute Disease studies →Consorci Sanitari de l'Alt Penedès i Garraf is the lead sponsor of 41 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Medical doctors assigned to this group will incorporate a Levels of Diagnostic and Therapeutic Intervention tool into their clinical practice
Other: Levels of Diagnostic and Therapeutic Intervention tool by Fontecha and col.
Medical doctors assigned to this group will continue their clinical practice as usual
Other: Usual clinical practice
During the intervention periods, participating physicians will integrate into their usual clinical practice a tool for adjusting diagnostic and therapeutic intensity designed by Fontecha-Gómez and colleagues. The tool for adjusting the level of diagnostic and therapeutic intensity classifies patients' profiles into 5 groups based on the recommended level of adjustment.
The participating physicians will carry out the standard clinical practice currently performed in the study centers. This means that during this period, the diagnostic and therapeutic adjustment tool or any similar tool will not be introduced into routine clinical practice.
In-hospital Patient Mortality at 90 days from hospital discharge
Percentage of patients who die during hospitalization until 90 days from hospital discharge.
Time frame: 90 days from hospital discharge
In-hospital Patient Mortality at 6 months from hospital discharge
Percentage of patients who die during hospitalization until 6 months from hospital discharge.
Time frame: 6 months from hospital discharge
In-hospital Patient Mortality at 1 year from hospital discharge
Percentage of patients who die during hospitalization until 1 year from hospital discharge.
Time frame: 1 year from hospital discharge
Delirium Incidence
Percentage of patients with delirium occurrence during hospital admission (delirium already present at the time of admission will not be considered). Delirium will be evaluated through Confusion Assessment Method (CAM)
Time frame: hospital discharge, assessed up to day 90
Pressure Ulcer Incidence
Percentage of patients with pressure ulcer occurrence during hospital admission (pressure ulcers already present at the time of admission will not be considered).
Time frame: hospital discharge, assessed up to day 90
Hospital stay
Hospital stay in days
Time frame: hospital discharge, assessed up to day 90
Hospital readmission for any reason
Percentage of patients readmitted for any reason within 30 days of hospital discharge.
Time frame: 30 days from hospital discharge
Hospital readmission for same reason
Percentage of patients readmitted for the same reason within 30 days of hospital discharge.
Time frame: 30 days from hospital discharge
Patients admitted to the Intensive Care Unit (ICU)
Percentage of patients admitted to the ICU during hospitalization
Time frame: hospital discharge, assessed up to day 90
Calls to the "on-call doctor"
Number of calls to the "on-call doctor" during hospital admission
Time frame: hospital discharge, assessed up to day 90
Healthcare expenditure
Descriptive analysis of healthcare expenditure associated with each intervention, using the billing data from the center.
Time frame: through study completion, an average of 1.5 years
Mortality at ICU
Percentage of patients admitted to the ICU
Time frame: hospital discharge, assessed up to day 90
Plan to share: Yes — IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research proposels and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).
Supporting information: Study protocol
Time frame: After publication of main results of the study.
Access criteria: IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
Feasibility issues (organizational changes required to perform the trial are not feasible)
Feasibility issues (organizational changes required to perform the trial are not feasible)
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is withdrawn, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Consorci Sanitari de l'Alt Penedès i Garraf